Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10214528 Bicyclic heterocycles as FGFR4 inhibitors

Patent 10214528 was granted and assigned to Incyte on February, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Incyte
Incyte
Date Filed
January 18, 2018
Date of Patent
February 26, 2019
Patent Applicant
Incyte
Incyte
Patent Application Number
15874299
Patent Citations
‌
US Patent 10040790 Bicyclic heterocycles as FGFR inhibitors
‌
US Patent 10016348 Two-phase composition comprising a fatty acid ester of sugar or a liquid alkyl polyglucoside, with an HLB < 8, and a C
Patent Citations Received
‌
US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 11472801 Crystalline forms of a FGFR inhibitor and processes for preparing the same
‌
US Patent 11840534 Substituted tricyclic compounds as FGFR inhibitors
0
‌
US Patent 11939331 Tricyclic heterocycles as FGFR inhibitors
0
‌
US Patent 12012409 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 12024517 Salts of an FGFR inhibitor
0
‌
US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent
0
‌
US Patent 12083124 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 11466004 Solid forms of an FGFR inhibitor and processes for preparing the same
‌
US Patent 10450313 Bicyclic heterocycles as FGFR inhibitors
0
•••
Patent Inventor Names
Liang Lu
0
Liangxing Wu
0
Wenqing Yao
0
Ding-Quan Qian
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10214528
Patent Primary Examiner
‌
Leslie A. Royds Draper

Find more entities like US Patent 10214528 Bicyclic heterocycles as FGFR4 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo